menu
    • menu

    Company profile for ALK

    NEW Drugs in Dev: 34
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ALK is a global allergy solutions company, with a wide range of allergy treatments, products and services that meet the unique needs of allergy sufferers, their families and healthcare professionals. At ALK, we have a proud heritage of pioneer research dating all the way back to our founders nearly 100 years ago. Back then, research was small-scale, the evidence for allergy immunotherapy was limited and medical science was sti...
    ALK is a global allergy solutions company, with a wide range of allergy treatments, products and services that meet the unique needs of allergy sufferers, their families and healthcare professionals. At ALK, we have a proud heritage of pioneer research dating all the way back to our founders nearly 100 years ago. Back then, research was small-scale, the evidence for allergy immunotherapy was limited and medical science was still in its infancy. Over the decades, things have changed immensely, and ALK has been responsible for many of the innovations we now take for granted in our understanding of allergy and its treatment.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ALKDenmark Flag
    Country
    Country
    Denmark
    Address
    Address
    Bøge Allé 6-8 DK-2970 Hørsholm
    Telephone
    Telephone
    (+45) 4574 7576
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.alk.net/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/alk-abello
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/alk_net?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alkeus Pharma Presents Gildeuretinol Data At ARVO 2026 Meeting
    Alkeus Pharma Presents Gildeuretinol Data At ARVO 2026 Meeting

    30 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/30/3284926/0/en/alkeus-pharmaceuticals-announces-presentation-of-gildeuretinol-data-during-the-association-for-research-in-vision-and-ophthalmology-arvo-2026-annual-meeting.html

    GLOBENEWSWIRE
    30 Apr 2026
    Share Share
    ALK To Present Q1 2026 Results On May 5
    ALK To Present Q1 2026 Results On May 5

    28 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/28/3282875/0/en/invitation-to-the-presentation-of-alk-s-first-quarter-2026-results-on-tuesday-5-may-2026.html

    GLOBENEWSWIRE
    28 Apr 2026
    Share Share
    ALK-Abelló Managers Disclose B-Share Transactions
    ALK-Abelló Managers Disclose B-Share Transactions

    08 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/08/3270546/0/en/Report-on-transactions-with-ALK-Abell%C3%B3-A-S-B-shares-and-associated-securities-by-managerial-staff.html

    GLOBENEWSWIRE
    08 Apr 2026
    Share Share
    Nuvalent Files Neladalkib NDA for Advanced ALK+ NSCLC
    Nuvalent Files Neladalkib NDA for Advanced ALK+ NSCLC

    07 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nuvalent-announces-submission-of-new-drug-application-to-fda-for-neladalkib-in-tki-pre-treated-advanced-alk-positive-nsclc-302735124.html

    PR NEWSWIRE
    07 Apr 2026
    Share Share
    Share-Based LTI Granted to Board and Key Employees
    Share-Based LTI Granted to Board and Key Employees

    01 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/01/3266347/0/en/Grant-of-share-based-long-term-incentive-instruments-to-members-of-the-Board-of-Management-and-key-employees.html

    GLOBENEWSWIRE
    01 Apr 2026
    Share Share
    EURneffy 1mg Approved in EU as First Needle-Free Adrenaline
    EURneffy 1mg Approved in EU as First Needle-Free Adrenaline

    31 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/31/3265184/0/en/EURneffy-1-mg-approved-across-the-EU-as-the-first-and-only-needle-free-adrenaline-treatment-for-young-children-15-kg-at-risk-of-anaphylaxis.html

    GLOBENEWSWIRE
    31 Mar 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search